Sign in to view content

Masked Safety Data from ZETA-1, an Ongoing 24-Week Phase 2 Clinical Trial of APX3330, an Oral Therapeutic Being Developed for the Treatment of Diabetic Retinopathy

Michael J Allingham, MD, PhD

Video
Published 2022

Related

Relationships Between Total Retinal Volume and Visual and Anatomic Outcome Measures in Patients With Diabetic Macular Edema in RIDE and RISE
Michelle V. Carle, MD. MMEd
On Demand Cases, Courses, and Papers
2019
Insights Into the Progression of Diabetic Retinopathy Severity Among Primary Care Patients With Diabetes in the United States
Geeta A. Lalwani, MD
Annual Meeting Talks
2020
Imaging, Digital, Angiography Symposium 1
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more